GlassScriptPhysician profile
Matthew S Austin
NPI 1518914886
$986,212.78
in general payments reported to CMS, 2019-2025
9 companies · $313K in 2025
The $313K reported for 2025 was more than what 96% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $6,158 · 2021: $51K · 2022: $102K · 2023: $399K · 2024: $59K · 2025: $313K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $649K · Consulting Fee: $108K · Travel and Lodging: $9,394 · Food and Beverage: $3,431 · Education: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $648,742.79 |
| Consulting Fee | $108,362.81 |
| Travel and Lodging | $9,394.41 |
| Food and Beverage | $3,431.01 |
| Education | $504.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $409,073.86 | 2021-2023 | Persona, Avenir, Rosa |
| Stryker Corporation | $371,799.34 | 2019-2025 | Insignia, Mako, Triathlon |
| Depuy Synthes Products, INC. | $70,829.59 | 2021-2023 | Velys, Attune, Actis |
| Corin USA | $55,757.66 | 2019 | |
| Medical Device Business Services, INC. | $38,375.24 | 2020-2023 | Attune, Actis |
| Omnilife Science, INC | $21,692.86 | 2020-2023 | Omnibotics 3.0 |
| Linkbio Corp | $18,118.47 | 2021-2022 | |
| Smith+Nephew, INC. | $555.01 | 2019-2023 | Real Intelligence |
| Heraeus Medical, LLC. | $10.75 | 2023-2025 | Palacos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,431,045.20 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.